We are live on ! Find out more
VPHM

VIROPHARMA INC
VPHM

Delisted

VPHM was delisted on the 23rd of January, 2014.

Back to rankings

174 hedge funds and large institutions have $1.98B invested in VIROPHARMA INC in 2013 Q2 according to their latest regulatory filings, with 174 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less call options, than puts

Call options by funds: $3.95M | Put options by funds: $4.16M

Holders
174
Holders Change
+174
Holders Change %
–
% of All Funds
5.68%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
174
Increased
–
Reduced
–
Closed
–
Calls
$3.95M
Puts
$4.16M
Net Calls
-$216K
Net Calls Change
-$216K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$262M +$241M +9,137,186 New
BBA
2
Baker Bros. Advisors
New York
$244M +$225M +8,528,603 New
PAI
3
Palo Alto Investors
California
$114M +$105M +3,968,818 New
BFA
4
BlackRock Fund Advisors
California
$113M +$104M +3,959,156 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$113M +$104M +3,950,508 New
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$69.1M +$63.6M +2,410,519 New
EAM
7
Eagle Asset Management
Florida
$60.4M +$55.6M +2,107,635 New
State Street
8
State Street
Massachusetts
$59.1M +$54.4M +2,061,331 New
BIT
9
BlackRock Institutional Trust
California
$50.7M +$46.7M +1,770,199 New
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$47.2M +$43.5M +1,648,200 New
Northern Trust
11
Northern Trust
Illinois
$40.5M +$37.3M +1,415,124 New
SCM
12
Scopia Capital Management
New York
$39.8M +$36.7M +1,389,308 New
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$35.1M +$32.3M +1,224,515 New
Citadel Advisors
14
Citadel Advisors
Florida
$33.9M +$31.2M +1,183,341 New
PI
15
Putnam Investments
Massachusetts
$33.8M +$31.1M +1,180,373 New
Massachusetts Financial Services
16
Massachusetts Financial Services
Massachusetts
$31.5M +$29M +1,100,250 New
TI
17
Turner Investments
Pennsylvania
$28.7M +$26.4M +1,000,633 New
PC
18
PointState Capital
New York
$25.8M +$23.7M +900,000 New
JP Morgan Chase
19
JP Morgan Chase
New York
$25.6M +$23.6M +894,812 New
FAM
20
Fred Alger Management
New York
$24.9M +$22.9M +869,688 New
CS
21
Credit Suisse
Switzerland
$24.7M +$22.7M +862,192 New
Goldman Sachs
22
Goldman Sachs
New York
$23.7M +$21.8M +826,442 New
DGI
23
Disciplined Growth Investors
Minnesota
$20.2M +$18.6M +704,535 New
AC
24
Apex Capital
California
$18.2M +$16.8M +636,700 New
WCM Investment Management
25
WCM Investment Management
California
$18.2M +$16.7M +633,691 New
1
2 3 4 5

VPHM Hedge Fund Activity: Q2 2013 in Review

174 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in VIROPHARMA INC (VPHM) for Q2 2013, worth a combined $1.98B.

Buyers outnumbered sellers: 174 funds opened new VPHM positions and 0 closed out — a net gain of 174 holders — while 0 added to existing stakes and 0 trimmed.

  • 174 institutional investors held VIROPHARMA INC (VPHM) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.98B of VIROPHARMA INC stock for Q2 2013.
  • 174 funds opened new VIROPHARMA INC positions in Q2 2013 and 0 closed out, a net change of +174 holders.

Based on aggregated 13F filings for Q2 2013.